Stay updated on Denosumab & Pembrolizumab in RCC Clinical Trial
Sign up to get notified when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.

Latest updates to the Denosumab & Pembrolizumab in RCC Clinical Trial page
- Check3 days agoChange DetectedRevision metadata updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check31 days agoChange DetectedRevision label updated to v3.5.0; the previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check67 days agoChange DetectedAdded Revision: v3.4.2 and removed older maintenance notices (including Revision: v3.4.1) as part of minor site upkeep. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check74 days agoChange DetectedA government funding lapse notice appears on the page with operating-status guidance, and the site revision is updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check81 days agoChange DetectedMinor UI and metadata updates: Show glossary option added, label capitalizations adjusted (Last Update Submitted that Met QC Criteria; No FEAR Act Data), and a new footer note 'Revision: v3.4.0' replacing the previous version.SummaryDifference0.2%

Stay in the know with updates to Denosumab & Pembrolizumab in RCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Denosumab & Pembrolizumab in RCC Clinical Trial page.